Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DSM
Alliance to develop new treatment of heart and vascular diseases
April 26th, 2005
DSM, Universiteit Maastricht (UM) and academic hospital Maastricht (azM) have entered into a strategic agreement for joint research and development projects. The first concrete project, Bioterials, will result in new heart and vascular disease treatments on the basis of biomaterials. Biomaterials focus on non-human materials for the recovery and support of bodily functions. Application examples are biopolymer, tissue engineering (artificial creation of human tissue) and orthopaedic implants. The partners will do the research in the field of biomaterials in three directions: The first research will be in the development of a new...
Source: Cardiovascular Business Week (2005-04-26)
|
